Work In Tech

Find your next role at Canada's fastest-growing tech companies

Interface Biologics, Inc.
Interface Biologics, Inc.
interfacebiologics.com

Locations

Toronto, ON, Canada · North York, Toronto, ON, Canada

Size

1 - 10 employees

founded in

2001

Interface Biologics, Inc. (IBI) is a commercial stage company that develops transformative biomedical polymer technology to improve the safety and effectiveness of medical devices. Their patent-protected technologies include anti-thrombogenic additives for blood contacting medical devices and polymer enabled combination drug delivery devices. IBI has exclusive Endexo technology licensing agreements with AngioDynamics for vascular access catheters and with Fresenius Medical Care for chronic dialysis systems. AngioDynamics’ BioFlo PICCS, Ports and DuraMax Dialysis Catheter with IBI’s Endexo technology have received FDA clearance and are gaining commercial traction. IBI also has a joint venture commercial agreement with Qualimed to develop a drug-coated balloon based on IBI’s Kinesyx technology. The company was founded in 2001 and is headquartered in Toronto, Canada at the acclaimed MaRS Innovation Centre.

Something looks off?
Open jobs at Interface Biologics, Inc.
Powered by Getro